July 12, 2019

INTERVIEW: Applied Graphene Materials excited about its new products – and with good reason

Applied Graphene Materials (LON: AGM) CEO Adrian Potts joins DirectorsTalk to discuss the launch of its new coatings product and also the advancement of applications for Water-Based Anti-Corrosion Coatings. Adrian..

INTERVIEW: Jubilee Metals Group Adding to earnings while aggressively pursuing further projects

Jubilee Metals Group (LON: JLP) CEO Leon Coetzer joins DirectorsTalk to discuss the lates projects update. Leon talks us through the update highlights, provides details on its focus on copper,..

INTERVIEW: Volta Finance – Questions from the Hardman Investor Forum

Volta Finance (LON: VTAS) is the topic of conversation when Mark Thomas joins DirectorsTalk. Mark explains why there is no read across from the problems seen at Woodford and H20,..

Ashmore Group plc Strong growth in AuM of 24%

Ashmore Group plc (LON:AHT), the specialist Emerging Markets asset manager, announced today the following update to its assets under management in respect of the quarter ended 30 June 2019. Assets..

Sophos Group Group revenue growth of 7% Next generation billings grew 43%

Sophos Group plc (LON: SOPH), a leading provider of next-generation cloud-enabled enduser and network cybersecurity solutions, has today issued its trading update for the quarter-ended 30 June 2019. Financial highlights..

Euromoney Institutional Investor PLC appoint Tim Pennington as Non-executive Director

Euromoney Institutional Investor PLC (LON:ERM), the global B2B information business, providing price discovery, essential market intelligence and events, today announced that the Board has appointed Tim Pennington as an additional..

Sophos Group PLC announces departure of CFO Nick Bray

Sophos Group PLC (LON:SOPH) today announced that Nick Bray, Chief Financial Officer, has informed the Board of his decision to take up a new position at a private equity-owned business..

AstraZeneca PLC Imfinzi granted US Orphan Drug Designation for small cell lung cancer

AstraZeneca (LON: AZN) has today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Imfinzi (durvalumab) for the treatment of small cell lung..

Hiscox Ltd Trading Update

Hiscox Ltd (LON:HSX), the international specialist insurer, today provided an update on its financial performance for the first six months of 2019. The Group expects to deliver a profit before..

boohoo group plc CEO Growth Share Plan Update

boohoo group plc (LON: BOO), a leading online fashion group, announced today that John Lyttle, Chief Executive Officer, has subscribed for 195 A ordinary shares of 1 pence each in..

Flowtech Fluidpower expects another year of solid progress

Flowtech Fluidpower plc (LON: FLO) the AIM listed specialist technical fluid power products supplier, announced today the following unaudited trading update on its performance for the six-month financial reporting period..

DCC plc Good Growth in First Quarter

DCC plc (LON: DCC), the leading international sales, marketing and support services group, has today issued a Interim Management Statement in advance of the Company’s AGM to be held in..

Search

Funds

July 12, 2019

Search

Funds

July 12, 2019

FTSE 100

Funds